If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

  • This share is currently suspended. It was suspended at a price of 305.00
  • There is currently no data for TET

Director/PDMR Shareholding

3 Sep 2013 09:23

RNS Number : 0933N
Treatt PLC
03 September 2013
 



 

3 September 2013

 

 

TREATT PLC

("Treatt" or "the Company")

 

 

Notification of Transactions of Directors

In accordance with Disclosure and Transparency Rule 3.1.2.(R), the following Directors notified the Company on 2 September 2013 of the exercise of their options under the 2010 Save As You Earn Share Option Scheme ("SAYE"), details of which are below:

 

Director

Richard Hope

Anita Haines

Position

Group Finance Director

Group HR Director

Scheme

SAYE

SAYE

Price Paid Per Ordinary Share

222p

222p

Number of Shares

Acquired

1,297

1,297

Holding/Interest Following Notification

27,669 Ord shares

10,136 Ord shares

% Holding of Issued Share Capital

0.26%

0.10%

The SAYE is an all employee scheme operated for UK employees which was approved by shareholders in February 2005. The options are exercisable at the end of a three year saving plan.

 

Contact details

 

Anita Steer

Company Secretary

++ 44 1284 770028

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGIGDCDDGBGXX
Date   Source Headline
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:01 amRNSTransaction in Own Shares
13th May 20257:00 amRNSHalf Year Results
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20255:34 pmRNSReplacement: Transaction in Own Shares
11th Apr 20252:25 pmRNSHolding(s) in Company
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20259:07 amRNSHolding(s) in Company
10th Apr 20257:01 amRNSShare Buyback Programme
10th Apr 20257:00 amRNSTrading Update
25th Mar 202511:30 amRNSVoting Rights and Capital
24th Mar 20257:00 amRNSDirectorate Change
19th Mar 20253:33 pmRNSDirector/PDMR Shareholding
6th Feb 20254:18 pmRNSHolding(s) in Company
4th Feb 202511:55 amRNSHolding(s) in Company
30th Jan 20254:17 pmRNSResult of AGM
30th Jan 20257:00 amRNSAGM Trading Update
20th Dec 202411:24 amRNSNotification of Transactions of Directors
17th Dec 20244:07 pmRNSAnnual Report and Notice of Annual General Meeting
17th Dec 20241:44 pmRNSNotification of Transactions of Directors
4th Dec 20241:47 pmRNS2024 Final Dividend
4th Dec 20247:00 amRNSFull Year Results
2nd Dec 20247:00 amRNSBlock Listing Six Monthly Return
2nd Dec 20247:00 amRNSBlock Listing Six Monthly Return
15th Nov 20247:00 amRNSBoard Change
16th Oct 202412:00 pmRNSChange in Director's Duties
10th Oct 20247:00 amRNSTrading Update
24th Sep 20242:06 pmRNSDirector/PDMR Shareholding
20th Aug 202411:06 amRNSNotification of Transactions of Directors
12th Jul 202410:49 amRNSDirector/PDMR Shareholding
4th Jun 202410:35 amRNSBlock Listing Six Monthly Return
4th Jun 202410:25 amRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.